[Initial findings in the treatment of Meniere's disease with betahistine hydrochloride (Betaserc)].
D006631:Amine Oxidase (Copper-Containing) / Q000037:antagonists & inhibitors*; D001621:Betahistine / Q000627:therapeutic use; D005021:Ethylamines / Q000627:therapeutic use*; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use*
D005021:Ethylamines; D011725:Pyridines; D006631:Amine Oxidase (Copper-Containing); D001621:Betahistine
Eerste bevindingen bij de behandeling van de ziekte van Ménière met betahistine hydrochloride (Betaserc.